Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
128.80
-0.20 (-0.16%)
Apr 28, 2025, 11:45 AM AST
-12.97%
Market Cap 2.58B
Revenue (ttm) 394.00M
Net Income (ttm) 79.85M
Shares Out 20.00M
EPS (ttm) 3.99
PE Ratio 32.31
Forward PE n/a
Dividend 2.50 (1.94%)
Ex-Dividend Date May 4, 2025
Volume 7,529
Average Volume 37,689
Open 129.00
Previous Close 129.00
Day's Range 128.60 - 129.60
52-Week Range 107.00 - 156.00
Beta n/a
RSI 50.34
Earnings Date May 7, 2025

About TADAWUL:4016

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic ... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1998
Employees 632
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4016
Full Company Profile

Financial Performance

In 2024, TADAWUL:4016's revenue was 394.00 million, an increase of 16.42% compared to the previous year's 338.44 million. Earnings were 79.85 million, an increase of 21.30%.

Financial Statements

News

There is no news available yet.